Chimeric antigen receptor T-cell therapy for refractory post-transplant lymphoproliferative disorder after lung

Kaleb Veit1, Tahuanty Peña2, Julia Klesney-Tait2

  • 1University of Nebraska Medical Center, Omaha, Nebraska.

JHLT Open
|March 27, 2025
PubMed